Fairmount Funds Management as of March 31, 2022
Portfolio Holdings for Fairmount Funds Management
Fairmount Funds Management holds 22 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Insmed Com Par $.01 (INSM) | 10.8 | $46M | 1.9M | 23.50 | |
| Global Blood Therapeutics In | 9.7 | $41M | 1.2M | 34.64 | |
| Argenx Se Sponsored Adr (ARGX) | 9.3 | $39M | 124k | 315.31 | |
| Axsome Therapeutics (AXSM) | 9.2 | $39M | 943k | 41.39 | |
| Enanta Pharmaceuticals (ENTA) | 7.9 | $33M | 469k | 71.18 | |
| Biohaven Pharmaceutical Holding | 6.7 | $28M | 239k | 118.57 | |
| ACADIA Pharmaceuticals (ACAD) | 6.6 | $28M | 1.2M | 24.22 | |
| Keros Therapeutics (KROS) | 5.1 | $22M | 397k | 54.38 | |
| Nuvalent Inc-a (NUVL) | 4.4 | $19M | 1.3M | 13.89 | |
| Point Biopharma Global | 4.4 | $18M | 2.3M | 7.97 | |
| Miragen Therapeutics (VRDN) | 4.1 | $18M | 944k | 18.49 | |
| Tyra Biosciences (TYRA) | 3.3 | $14M | 1.3M | 10.70 | |
| Amarin Corp Spons Adr New (AMRN) | 3.2 | $14M | 4.1M | 3.29 | |
| Protagonist Therapeutics (PTGX) | 3.1 | $13M | 550k | 23.68 | |
| Cogent Biosciences (COGT) | 2.8 | $12M | 1.6M | 7.49 | |
| Olema Pharmaceuticals (OLMA) | 2.7 | $11M | 2.7M | 4.26 | |
| Instil Bio | 1.7 | $7.2M | 674k | 10.75 | |
| Iovance Biotherapeutics (IOVA) | 1.5 | $6.5M | 390k | 16.65 | |
| Astria Therapeutics (ATXS) | 1.4 | $6.1M | 912k | 6.71 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.1 | $4.6M | 927k | 4.99 | |
| Annexon (ANNX) | 0.8 | $3.4M | 1.2M | 2.73 | |
| Allakos (ALLK) | 0.2 | $838k | 147k | 5.69 |
